TVRD financials

Tvardi Therapeutics (TVRD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

TVRD income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$26.75M-$18.21M-3.26
2024$7.14M$6.52M-$28.11M-$29.40M-11.42
2023$20.97M$14.79M-$121.50M-$118.51M-78.78
2022$41.87M$34.60M-$87.53M-$85.47M-57.36
2021$23.03M–-$89.08M-$88.44M-62.64
2020$135.08M–$5.38M$8.41M6.48